Tag: mist-2

February 25, 2019

Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis

Eyenovia (NASDAQ:EYEN) has announced positive results from its second MicroStat Phase III study called MIST-2. As quoted in the press...
December 3, 2018

Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study

Eyenovia (NASDAQ:EYEN) today announced that it has completed patient enrollment in its Phase III MIST-1 study and enrolled the first...